Status:
RECRUITING
An Observational Study of Local Relapse After High Grade Osteosarcoma
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Osteosarcoma
Eligibility:
All Genders
Brief Summary
multicenter retrospective and prospective study in patients with high-grade osteosarcoma
Detailed Description
This is a multicenter retrospective and prospective study that will analyze all cases with of diagnosis of local relapse in high-grade osteosarcoma from 01 January 1980 and all new cases referring to ...
Eligibility Criteria
Inclusion
- Patients who experienced LR as first event of recurrence after treatment for localized high-grade osteosarcoma of bone, including cases with synchronous lung metastases
- Adequate patient compliance to follow-up visits
- Written informed consent prior to any study-specific analysis and/or data collection
- No age limits
Exclusion
- Cases of LR demonstrated after \> 3 months after metastatic disease
- Impossibility to ensure adequate compliance
Key Trial Info
Start Date :
June 13 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06017518
Start Date
June 13 2022
End Date
June 30 2026
Last Update
September 22 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Ortopedico Rizzoli
Bologna, BO, Italy, 40136
2
Azienda Ospedaliero-Universitaria Pisana
Pisa, PI, Italy, 56126